3.71 USD
↘ 0.10 (2.62%)AT CLOSE (11:59 AM EDT)
Oramed Pharmaceuticals Inc.
ORMPNASDAQ • USD
3.70
↘ 0.01 (0.24%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
3.70
↘ 0.01 (0.24%)
Market: CLOSED
Open?$3.81
High?$3.81
Low?$3.65
Prev. Close?$3.81
Volume?99.8K
Avg. Volume?207.7K
VWAP?$3.73
Rel. Volume?0.48x
Bid / Ask
Bid?$3.16 × 100
Ask?$4.21 × 100
Spread?$1.05
Midpoint?$3.69
Valuation & Ratios
Market Cap?151.8M
Shares Out?40.9M
Float?32.3M
Float %?81.2%
P/E Ratio?1.39
P/B Ratio?0.64
EPS?$2.67
Dividend?6.83%
Ex-Dividend?N/A
Oramed Pharmaceuticals Inc. (ORMP) trades at $3.71 per share. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a weak Piotroski F-Score of 0/9, exceptional Return on Equity (45.8%) and a bullish Golden Cross on the moving averages. On the valuation side, ORMP appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY 10036
Phone: 646-844-1164
NEW YORK, NY 10036
Phone: 646-844-1164
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?58
Momentum?65
Short Sent.?78
Piotroski F-Score?0/9Weak
Altman Z-Score?2.62Grey
Confidence?42%Low
Short InterestModerate
Short % of Float?1.97%Low
Short Interest?635.4K
Days to Cover?3.4
Free Float32.3M
Avg Daily Volume186.0K
Settlement Date2026-05-15
Financial Health
Current Ratio?6.45Strong
Quick Ratio?6.45Strong
Cash Ratio?1.25Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?1.4CHEAP▾
Peers100
S&P97
P/B?0.64CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-9.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?45.8%STRONG▾
Peers50
S&P90
ROA?40.6%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-73514000
Enterprise Value?$138.6M
Fundamentals ratios updated end of day